Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention

Wenguang Lai1,2,3, Xiaoli Zhao4, Sijia Yu2,3,5

  • 1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.

Insights

Chronic kidney disease (CKD) significantly increases the risk of developing heart failure with reduced ejection fraction (HFrEF) after percutaneous coronary intervention (PCI). This association highlights the need for proactive management in CKD patients undergoing PCI to prevent HFrEF and reduce mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Research

Background:

  • Chronic kidney disease (CKD) is prevalent in patients at high risk for heart failure with reduced ejection fraction (HFrEF).
  • The impact of CKD on incident HFrEF in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains understudied.

Purpose of the Study:

  • To investigate the association between chronic kidney disease (CKD) and the incidence of heart failure with reduced ejection fraction (HFrEF).
  • To examine the impact of CKD on all-cause mortality in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • A cohort of 2,356 patients with baseline left ventricular ejection fraction (LVEF) ≥ 40% undergoing PCI between January 2007 and December 2018 was analyzed.
  • Incident HFrEF was defined as a follow-up LVEF < 40% within 3-12 months post-discharge.
  • Multivariable logistic regression was employed to assess the relationship between CKD and incident HFrEF, adjusting for multiple confounders.

Main Results:

  • Of the 2,356 patients, 18.5% had CKD, and 3.5% developed incident HFrEF.
  • The incidence of HFrEF was significantly higher in the CKD group (6.9%) compared to the non-CKD group (2.8%; p < 0.001).
  • CKD was identified as an independent risk factor for incident HFrEF (aOR = 1.75; p = 0.035), and patients with incident HFrEF had higher all-cause mortality (26.5% vs. 8.1%; p < 0.001).

Conclusions:

  • CKD is independently associated with an increased risk of developing HFrEF following PCI in patients with CAD.
  • The presence of CKD in patients undergoing PCI is linked to higher all-cause mortality.
  • Implementing more aggressive preventive strategies for HFrEF is crucial for patients with CKD undergoing PCI.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
213
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
67
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
89
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
92
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
54
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
69